: Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds
Many employers hold off on coverage of Wegovy and similar drugs amid cost concerns and the prospect of cheaper options down the road
After a sharp run for Arm shares recently, they looked set to give back some of their gains after Wednesday...
Apple Inc.’s new ad for the latest iPad is a shockingly bad image for a company that has for years...
Robinhood says it snapped up business from brokerage rivals and made inroads among gold investors.
Biden’s policies are seen as much more friendly to gig workers, and his re-election could offer a fresh challenge for...
Regional banks and the federal government are big losers of higher rates, but so are cities reeling from wobbling commercial...
Investors were liking the latest numbers from AppLovin on Wednesday, as its stock headed higher in the extended session.